Taken together, we propose a model that posits that, in MYCN-amplified neuroblastoma, high levels of MYCN upregulate the master regulator TFAP4, which in turn activates downstream oncogenic signaling pathways to promote cell cycle progression and inhibit neuroblastoma differentiation. This evidence concerns the gene MYCN and neuroblastoma.